Digital Health Views & Analysis | pharmaphorum

Friday 3 April 2026

Views & Analysis

Digital

Changing Faces: Digital and supplier for August 2024

Welcome to the August edition of Changing Faces’ digital and supplier edition. This was a bit of a slower month, but it wasn’t completely without notable moves.

Digital

pharmaphorum podcast Episode 151a - female listening to podcast

The Life Sciences Generative AI Council and a sustainable te...

The Life Sciences Generative AI Council aims to bring together the best minds in pharma, academia, and technology to advance the use of GenAI in life sciences R&D, seeking through pinpo

Digital

customer data icons download banner

Sponsored

How to deal with fragmented data - A $12.9 million challenge

In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.

Digital

structure framework illustration

Adopting AI platforms: A structured framework for thoughtful...

The adoption of AI platforms, particularly in sectors such as drug discovery and healthcare, is a complex and critical process.

Digital

man looking out of a window

Mixed reactions among HCPs as lecanemab and donanemab secure...

Last month, the FDA granted approval to Eli Lilly’s donanemab - or Kisunla - for the treatment of Alzheimer’s disease.

Digital

Solving Sudoku

Tech & Trials: What’s all this about AI, then?

Welcome to Tech & Trials – a guided tour to the world of AI and clinical trials.